Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | MYC | P01106 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18610991 | 0.87 | KDM4E (0.34) | KDM4ECYP1A2TDP1ALDH1A1CYP2C19 | |
| SCHEMBL9927339 | 0.79 | CYP1A2 (0.43) | KDM4ECYP1A2MYCKMT2ALMNA | |
| SCHEMBL17616034 | 0.77 | GPR3 (0.39) | KDM4ECYP1A2MYCKMT2AUSP2 | |
| SCHEMBL25971764 | 0.75 | — | — | |
| SCHEMBL20153656 | 0.75 | CYP2D6 (0.33) | TDP1SMN1; SMN2 | |
| SCHEMBL26168260 | 0.71 | ALDH1A1 (0.40) | KDM4EKMT2ALMNAALDH1A1 | |
| SCHEMBL26168259 | 0.71 | ALDH1A1 (0.40) | KDM4EKMT2ALMNAALDH1A1 | |
| SCHEMBL26168253 | 0.71 | MEN1 (0.35) | KDM4EKMT2AUSP2LMNAALDH1A1 | |
| SCHEMBL26168258 | 0.71 | MEN1 (0.35) | KDM4EKMT2AUSP2LMNAALDH1A1 | |
| SCHEMBL26168267 | 0.69 | ALDH1A1 (0.32) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230015063-A1 | METAL-ASSISTED DELAYED FLUORESCENT EMITTERS CONTAINING TRIDENTATE LIGANDS | UNIV ARIZONA STATE (US) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230015063-A1 | METAL-ASSISTED DELAYED FLUORESCENT EMITTERS CONTAINING TRIDENTATE LIGANDS | SLC30A6, SLC30A5, BRI3BP | KDM4E 4862/4885CYP1A2 4243/4885MYC 4720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.